HealthInvest Partners AB
Latest statistics and disclosures from HealthInvest Partners AB's latest quarterly 13F-HR filing:
- Top 5 stock holdings are UNH, LLY, GILD, COR, MRK, and represent 32.94% of HealthInvest Partners AB's stock portfolio.
- Added to shares of these 10 stocks: UNH (+$9.5M), LLY (+$9.0M), COR (+$7.9M), MRK (+$7.0M), TMO (+$5.9M), HRMY, AMGN, CNC, MOH, ELV.
- Started 13 new stock positions in MOH, ELV, HRMY, FUSN, MDGL, IONS, MORF, CNC, Ambrx Biopharma, IMCR. AMGN, AUTL, CABA.
- Reduced shares in these 10 stocks: UTMD (-$9.4M), VTRS (-$5.3M), GSK (-$5.3M), CAH (-$5.2M), CVS, ZVRA, AUPH, CI, , MRNA.
- Sold out of its positions in ALNY, AUPH, Bellus Health, BCYC, BMRN, CVS, DNLI, DOCS, GSK, IMGN. KRTX, ZVRA, MRVI, MASI, MRNA, OM, PSTX, Prometheus Biosciences, UTMD, VTRS, RPRX.
- HealthInvest Partners AB was a net buyer of stock by $76M.
- HealthInvest Partners AB has $128M in assets under management (AUM), dropping by 146.69%.
- Central Index Key (CIK): 0001381843
Tip: Access up to 7 years of quarterly data
Positions held by HealthInvest Partners AB consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for HealthInvest Partners AB
HealthInvest Partners AB holds 45 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
UnitedHealth (UNH) | 7.6 | $9.7M | +4756% | 18k | 526.47 |
|
Eli Lilly & Co. (LLY) | 7.2 | $9.2M | +4617% | 16k | 582.92 |
|
Gilead Sciences (GILD) | 6.3 | $8.0M | +62% | 99k | 81.01 |
|
AmerisourceBergen (COR) | 6.3 | $8.0M | +12497% | 39k | 205.38 |
|
Merck & Co (MRK) | 5.6 | $7.2M | +5816% | 66k | 109.02 |
|
Thermo Fisher Scientific (TMO) | 4.7 | $6.1M | +5088% | 11k | 530.79 |
|
Cardinal Health (CAH) | 3.8 | $4.8M | -52% | 48k | 100.80 |
|
Harmony Biosciences Hldgs In (HRMY) | 3.7 | $4.7M | NEW | 145k | 32.30 |
|
Amgen (AMGN) | 3.6 | $4.6M | NEW | 16k | 288.02 |
|
Centene Corporation (CNC) | 3.6 | $4.6M | NEW | 62k | 74.21 |
|
Molina Healthcare (MOH) | 3.5 | $4.5M | NEW | 13k | 361.31 |
|
Bristol Myers Squibb (BMY) | 3.5 | $4.5M | +35% | 88k | 51.31 |
|
Cigna Corp (CI) | 3.5 | $4.5M | -6% | 15k | 299.45 |
|
Anthem (ELV) | 3.5 | $4.5M | NEW | 9.5k | 471.56 |
|
Stryker Corporation (SYK) | 3.0 | $3.8M | +6365% | 13k | 299.46 |
|
Boston Scientific Corporation (BSX) | 2.9 | $3.7M | +6008% | 65k | 57.81 |
|
Vertex Pharmaceuticals Incorporated (VRTX) | 2.9 | $3.7M | +4126% | 9.1k | 406.89 |
|
Regeneron Pharmaceuticals (REGN) | 2.7 | $3.5M | +4178% | 4.0k | 878.29 |
|
Abbvie (ABBV) | 2.6 | $3.3M | +2513% | 21k | 154.97 |
|
Iqvia Holdings (IQV) | 1.9 | $2.4M | +4709% | 10k | 231.38 |
|
Dex (DXCM) | 1.8 | $2.2M | +5939% | 18k | 124.09 |
|
Neurocrine Biosciences (NBIX) | 1.3 | $1.7M | +6683% | 13k | 131.76 |
|
Edwards Lifesciences (EW) | 1.2 | $1.6M | +5746% | 21k | 76.25 |
|
Option Care Health Com New (OPCH) | 1.0 | $1.3M | +4957% | 37k | 33.69 |
|
Pfizer (PFE) | 1.0 | $1.2M | +3409% | 43k | 28.79 |
|
Ionis Pharmaceuticals (IONS) | 1.0 | $1.2M | NEW | 24k | 50.59 |
|
Fusion Pharmaceuticals (FUSN) | 0.9 | $1.2M | NEW | 125k | 9.61 |
|
Cytokinetics Com New (CYTK) | 0.8 | $980k | +2566% | 12k | 83.49 |
|
Bridgebio Pharma (BBIO) | 0.8 | $968k | +2604% | 24k | 40.37 |
|
EXACT Sciences Corporation (EXAS) | 0.7 | $899k | +4436% | 12k | 73.98 |
|
Intra Cellular Therapies (ITCI) | 0.7 | $877k | +4093% | 12k | 71.62 |
|
Ambrx Biopharma | 0.6 | $824k | NEW | 58k | 14.24 |
|
Krystal Biotech (KRYS) | 0.6 | $822k | +4665% | 6.6k | 124.06 |
|
Amicus Therapeutics (FOLD) | 0.5 | $691k | +8692% | 49k | 14.19 |
|
Shockwave Med (SWAV) | 0.5 | $673k | +10931% | 3.5k | 190.56 |
|
Merus N V (MRUS) | 0.5 | $669k | +8405% | 24k | 27.50 |
|
Inspire Med Sys (INSP) | 0.5 | $657k | +6109% | 3.2k | 203.43 |
|
Arcellx Common Stock (ACLX) | 0.5 | $633k | +7928% | 11k | 55.50 |
|
Autolus Therapeutics Spon Ads (AUTL) | 0.5 | $621k | NEW | 96k | 6.44 |
|
Madrigal Pharmaceuticals (MDGL) | 0.5 | $586k | NEW | 2.5k | 231.38 |
|
Immunocore Hldgs Ads (IMCR) | 0.4 | $535k | NEW | 7.8k | 68.32 |
|
Cabaletta Bio (CABA) | 0.4 | $477k | NEW | 21k | 22.70 |
|
Morphic Hldg (MORF) | 0.3 | $432k | NEW | 15k | 28.88 |
|
Akero Therapeutics (AKRO) | 0.3 | $360k | +9196% | 15k | 23.35 |
|
Prothena Corp SHS (PRTA) | 0.2 | $303k | +6267% | 8.3k | 36.34 |
|
Past Filings by HealthInvest Partners AB
SEC 13F filings are viewable for HealthInvest Partners AB going back to 2013
- HealthInvest Partners AB 2023 Q4 filed Jan. 30, 2024
- HealthInvest Partners AB 2022 Q4 filed Feb. 14, 2023
- HealthInvest Partners AB 2022 Q3 filed Oct. 21, 2022
- HealthInvest Partners AB 2022 Q2 filed July 8, 2022
- HealthInvest Partners AB 2022 Q1 filed May 5, 2022
- HealthInvest Partners AB 2021 Q4 filed Jan. 18, 2022
- HealthInvest Partners AB 2021 Q3 filed Nov. 8, 2021
- HealthInvest Partners AB 2021 Q2 filed Aug. 10, 2021
- HealthInvest Partners AB 2021 Q1 filed April 30, 2021
- HealthInvest Partners AB 2020 Q4 filed Feb. 5, 2021
- HealthInvest Partners AB 2017 Q4 filed Feb. 9, 2018
- HealthInvest Partners AB 2017 Q3 filed Nov. 13, 2017
- HealthInvest Partners AB 2017 Q2 filed Aug. 7, 2017
- HealthInvest Partners AB 2017 Q1 filed April 28, 2017
- HealthInvest Partners AB 2016 Q4 filed Jan. 24, 2017
- HealthInvest Partners AB 2016 Q3 filed Oct. 24, 2016